Ginsenoside Rg1 exerts its effects on autophagy and pyroptosis by modulating the miR-375–3p/ATG2B/PTEN-AKT pathway, thereby mitigating the pathogenesis and progression of NAFLD. The gene discussed is AKT1; the disease is metabolic dysfunction-associated steatotic liver disease.